2026
Aartsma-Rus A et Al. « TREAT-NMD advisory committee for therapeutics: Preclinical and clinical learnings from 15 years of TACT. » J Neuromuscul Dis: 22143602261438534
Beard, N et Al.
« Impact of downstream purification process and AAV serotype on protein-impurity clearance. »
Mol Ther Adv 34(2): 201752.
Boespflug-Tanguy, O
« Death following high-dose AAV9 gene therapy in a patient with advanced SMA-PME. »
Mol Ther.
Costa-Verdera H et Al.
« Identification of alterations of immunometabolism associated with Pompe disease. »
Cell Mol Life Sci 83(1).
Do Cao J et Al.
« Imlifidase enables AAV gene therapy in a seropositive Crigler-Najjar patient: On the verge of a paradigm shift. »
Mol Ther 34(5): 2571-2572.
